KKR acquires Alliance Tires from Warburg Pincus for $500m.

Warburg Pincus had acquired control of Alliance Tires from Fishman Holdings at a company value of $50 million in 2007.

April 16, 2013 22:15
Dollar bills.

Dollar bills 370. (photo credit: Steve Marcus / Reuters)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


KKR LLC will acquire a 75-percent controlling interest in Alliance Tire Group Ltd. from Warburg Pincus LLC, according to people familiar with the matter.

KKR will pay $500 million for Alliance Tire, generating a profit of hundreds of millions of dollars for Warburg Pincus, Reuters reported.

Warburg Pincus’s Indian partner in Alliance Tire, Yogesh Mahansaria, will keep a stake in the company and will work with KKR, the report said. KKR may ultimately own 90% of Alliance Tire and will partly finance the acquisition with debt, which will be backed by collateral. The closing will be in July, subject to various conditions.

Alliance Tire has bonds listed on the Tel Aviv Stock Exchange.

The bond debt totals NIS 135m.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection